VRDN Stock Jumps 6% After-Hours As Viridian Wins First FDA Approval
Shares of Viridian Therapeutics Inc (VRDN) jumped 6% after-hours on Friday after the U.S. Food and Drug Administration approved its drug Lumvoa for the treatment of thyroid eye disease.The drug is now available by prescription and marks the company’s first approved medicine and first commercial pro…